Skip to main content
. 2022 Sep 2;11(17):5196. doi: 10.3390/jcm11175196

Table 4.

CD44, MMP-2, and MMP-9 immunoreactivity of chromophobe renal cell carcinoma.

Overall Immunohistochemical Score CD44 MMP-2 MMP-9
Group 1 (low expression) (n (%)) 9 (50.00%) 7 (38.89%) 16 (88.89%)
Group 2 (moderate expression) (n (%)) 5 (27.78%) 5 (27.78%) 2 (11.11%)
Group 3 (high expression) (n (%)) 4 (22.22%) 6 (33.33%) 0 (0.00%)